Response to Liu et al., "Response to Ormaza Vera et al. "Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared to biologic-naıve patients with psoriasis: A retrospective cohort study'''' Article

publication date

  • May 1, 2025

webpage

published in

keywords

  • MACEs
  • biologics
  • cardiovascular risk
  • diabetes
  • dyslipidemia
  • hypertension
  • psoriasis
  • psoriasis therapy

start page

  • e159

end page

  • e160

volume

  • 92

issue

  • 5